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Abstract
Background
Urinary incontinence occurs in 40 % of women aged 65 years and over;
however,  only 15 % seek care and many delay healthcare seeking for
years.  Incontinence  is  associated  with  depression,  social  isolation,
reduced quality of life, falls and other comorbidities. It is accompanied
by  an  enormous  cost  to  the  individual  and  society.  Despite  the
substantial implications of urinary incontinence on social, psychological
and  physical  well-being  of  older  women,  the  impact  of  continence
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promotion on urinary symptom improvement and subsequent effects on
falls,  quality  of  life,  stigma,  social  participation  and  the  cost  of  care
remains unknown.
Methods
This study is a mixed methods multi-national open-label 2-arm parallel
cluster  randomized controlled trial  aiming to recruit  1000 community-
dwelling  incontinent  women  aged  65  years  and  older  across  Quebec,
Western  Canada,  France  and  United  Kingdom.  Participants  will  be
recruited through community organizations. Data will be collected at 6
time points:  baseline  and 1 week,  3  months,  6  months,  9  months  and
12 months after baseline. One of the primary objectives is to evaluate
whether  the  continence  promotion  intervention  improves  incontinence
symptoms  (measured  with  the  Patient  Global  Impression  of
Improvement  questionnaire,  PGI-I)  at  12  months  post  intervention
compared  to  the  control  group.  Other  co-primary  outcomes  include
changes in incontinence-related stigma, fall reduction, and incremental
cost-effectiveness  ratio  and  quality-adjusted  life  years.  Data  analysis
will account for correlation of outcomes (clustering) within community
organizations. A qualitative sub-study will explore stigma reduction.
Discussion
Community-based  continence  promotion  programs  may  be  a
cost-effective strategy to reduce urinary incontinence, stigma and falls
among  older  women  with  untreated  incontinence,  and  simultaneously
improve quality of life and healthy active life expectancy.
Trial registration
ClinicalTrials.gov: NCT01858493, registered 13 May 2013
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Dependency
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CI confidence interval
C-PIADS
Continence Psychosocial Impact of Assistive Devices
Scale
CUA cost-utility analysis
GEE generalized estimating equations
ICC intra-class correlation coefficient
ICER incremental cost-effectiveness ratio
ICIQ-FLUTS
International Consultation on Incontinence-Female Lower
Urinary Tract Symptoms
I-QOL Incontinence Quality of Life questionnaire
PIADS Psychosocial Impact of Assistive Devices Scale
PGI-I Patient Global Impression of Improvement
QALYs quality-adjusted life years
RCT randomized controlled trial
SF-6D 6-dimensional derivative of the 12-item SF-12
SF-12 12-item Short Form Health Survey
UK United Kingdom
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Background
The “taboo” syndrome of urinary incontinence has traditionally been
stigmatized among older women despite its remarkably high prevalence. In
Canada, the United Kingdom (UK) and France, almost 40 % of women
aged 65 years and older experience urinary incontinence, but little more
than 15 % seek care [ 1 – 4 ]. For many of these women, incontinence
symbolizes a decline into frailty and dependency [ 5 ]. Coping strategies
include the avoidance of social activities because of the potential for
embarrassment due to loss of bladder control in public, resulting in a
vicious cycle of reduced participation, social isolation, depression and loss
of independent living [ 6 ]. Urinary incontinence has consistently been
associated with shame [ 6 ], poor quality of life [ 6 , 7 ], poor self-rated
health [ 7 ], social isolation [ 6 ], and depression [ 6 , 8 ].
Incontinence is also linked to falls in older people, especially when
leakage is associated with urgency and rushing to the toilet in order to
prevent leakage [ 9 – 14 ]. Urge incontinence describes incontinence
associated with feelings of urgency, and has been shown to increase the
risk of falls by 50 % [9 ], with resultant fall-related injuries. The
relationship between falls and urinary incontinence can be explained by
shared underlying pathophysiological mechanisms, problems with
dual-tasking and cortical inhibition, and white matter hyperintensities
[ 15 – 17 ]. Urinary incontinence alone, and because of its association with
falls, has been associated with functional decline, nursing home admission
and significant out-of-pocket expenses [ 18 , 19 ]. This is a tragedy as
incontinence is largely treatable, with cures and improvements obtainable
at all ages even with conservative management [ 20 ].
Receipt of care for incontinence has been shown to lead to measurable
improvements in quality of life for older adults [ 21 ]. Unfortunately,
almost 85 % of incontinent older women never talk to a healthcare
practitioner or seek help for their condition [ 4 , 22 – 24 ]. Women who do
not seek help may consider their incontinence as not being serious enough,
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have inappropriate beliefs related to incontinence being a normal part of
aging, or may imagine that there is nothing that can be done to treat it [ 24 ,
25 ].
To date, few public health initiatives have targeted continence promotion,
despite its substantial social, psychological and physical ramifications for
older adults. Continence promotion involves challenging inappropriate
beliefs about incontinence, educating people that evidence-based
therapeutic options exist, and promoting improvements and cures at all
ages.
A pilot study compared the effectiveness of three experimental continence
promotion interventions against a control intervention on urinary symptom
improvement in 259 women aged 60 years and older with untreated
incontinence [ 26 ]. Participants were recruited from community
organizations [ 27 ]. The highest rate of urinary symptom improvement
occurred among participants who received a combined a 1-hour
constructivist learning workshop and a self-management program.
Sixty-six percent of participants in this group achieved improvement in
urinary symptoms, compared to 11 % of the control group (prevalence
difference 55 %, 95 % confidence interval (CI) 43 –67 %, intracluster
correlation 0). The number-needed-to-treat was 2 to achieve any
improvement in incontinence symptoms, and 5 to attain significant
improvement. Changes in knowledge and self-reported risk-reduction
behaviors paralleled rates of improvement [ 26 ].
The trial described in this protocol seeks to build on the successful pilot
study by testing whether the combined continence promotion intervention
can diminish incontinence-related stigma and falls, and improve quality of
life in addition to reducing urinary symptoms in older community-dwelling
women with incontinence. This cluster randomized controlled trial,
conducted internationally across the UK, France and Canada, will enable
accrual of a larger sample of culturally diverse women in whom to test the
continence promotion intervention. Prolonging the follow-up period to
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1 year, as compared to only 3 months in the pilot project, will allow us to
see if the benefits of the combined intervention can be maintained and
improved over 1 year. Further, this will permit time for women to seek
healthcare after they have tried some self-management tools. The impact
on fall reduction, quality of life and healthy active life expectancy will
also be assessed.
Study hypothesis
We hypothesize that, compared to the control group, receipt of the
combined continence promotion intervention will result in a significant
improvement in incontinence symptoms in at least 20 % of women, a
reduction in falls of 30 %, an expected change of 4.74 points on the
Incontinence Quality of Life Scale (I-QOL) and a gain in utility points on
the 6 dimensional derivative of the 12-item Short Form Health Survey
(SF-6D) of 0.0126, with which to calculate cost-effectiveness, cost-utility
and gains in healthy active life expectancy (Fig. 1 ).
Fig. 1
Logic model for the Continence Across Continents To Upend Stigma and
Dependency (CACTUS-D) trial
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Aim and study objectives
This study aims to evaluate the effectiveness of a continence promotion
program on incontinence symptoms, rate of falls, self-stigma and quality
of life in community-dwelling women with incontinence. In addition, the
study aims to evaluate the economic efficiency (incremental
cost-effectiveness and cost-utility) of providing community-based group
continence workshops to untreated older women with incontinence.
The objectives are to:
1. Evaluate whether the continence promotion intervention yields
significant improvement in incontinence symptoms at 1 year post
intervention compared to the control group.
2. Examine the effects of a continence promotion intervention on
self-stigma among women with untreated urinary incontinence.
3. Examine whether the receipt of a continence promotion intervention
leads to a reduction in falls and fall-related injuries.
4. Investigate the effects on quality of life and ascertain the
cost-effectiveness/cost-utility of the continence promotion program
for senior community-dwelling women.
Methods/Design
Design
The Continence Across Continents To Upend Stigma and Dependency
(CACTUS-D) study is an open-label, two-arm, parallel group, multi-
national cluster randomized controlled trial to be conducted across four
sites. A cluster design was deemed necessary to minimize the chances of
contamination between participants in different arms of the trial.
Individuals in a given community often share information through
discussion or direct observation. We surmised that older women rarely
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migrate to more than one community, hence we were confident that
community-level cluster randomization would minimize the chances of
contamination between the two arms of the trial.
The two arms in this trial are the continence promotion intervention arm
and the sham control arm. Figure 2  shows the flow of participants through
the study. A qualitative study relating to stigmatization associated with
continence will be embedded in the trial with a sub-group of participants.
The qualitative sub-study will be conducted across all four sites and will
seek to understand the effects of a continence promotion intervention on
self-stigma among women with untreated urinary incontinence.
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Fig. 2
Study flow
An economic evaluation will be conducted alongside the trial to examine
the difference in costs and outcomes between the continence promotion
intervention and control groups. If the continence promotion intervention
is deemed effective in both cost saving and improvement in outcomes, then
it is labeled dominant to the comparator. An economic evaluation is useful
for decision-making in comparing the cost and outcomes.
Study participants and setting
Eligibility of community organizations
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All community organizations in Quebec, Western Canada, France and the
UK will be eligible to participate and recruit older community-dwelling
women to the trial.
Eligibility of community-dwelling participants
Community-dwelling incontinent older women attending workshops
organized by participating community organizations will be eligible to take
part in the study. Women eligible for inclusion will be those aged 65 years
or older who are able to communicate either in English or in French. They
will have had to experience urinary incontinence with a frequency of two
or more times per week, and not sought professional advice for
incontinence symptoms within the past year. Exclusion criteria are women
diagnosed with dementia.
Ethical approval
The ethics review boards of the Institut Universitaire de Gériatrie de
Montréal in Quebec, the University of Brunel in the UK, the University of
Poitiers in France, and the University of Alberta in Alberta all approved
the study protocol by 26 March 2013 (ClinicalTrials.gov identifier:
NCT01858493). No personal identifiers will be used in any reports or
publications. Study procedures and benefits will be explained to the
enrolled women, and written consent will be obtained for baseline
measurements.
Recruitment and application of eligibility criteria
Organizations
Recruitment will be via community organizations. Eligible organizations
will be contacted via post, telephone or Email by a research assistant, and
invited to host an older women’s health workshop. Organizations will be
strategically selected by convenience sampling and word of mouth to
target older women. Previous organizations from the pilot study [ 26 , 27 ]
for this project will not be recruited. In order to be inclusive of diversity, a
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conscious effort will be made to approach culturally and socio-
economically diverse groups of women through outreach to different
community organizations in urban and rural areas from a wide area around
each study site. Once the organization has consented to host a workshop
and a local organizer has been selected from the organization, a mutually
convenient date will be chosen for the local event. The event will be
advertised via telephone calls, word of mouth, and targeted advertisements
featured in online or paper newsletters, and mailed invitations, printed by
the organization inviting their members to attend.
Participants
Following the recruitment of community organizations, all women who
decide to attend the workshops will be self-identified for participation in
the study. Recruitment strategies vary slightly per site, based on the
requirements of the respective ethics committees. In France and in Western
Canada, baseline data will be collected and participants will be screened
and enrolled to the study prior to the receipt of the intervention. In the UK
and Quebec, women will complete the baseline questionnaire prior to the
delivery of the intervention, but interested participants will sign the
consent form and return the baseline questionnaire only after the workshop
is completed. In a second screening stage, a research assistant confirms
eligibility status and interest in enrolling in the trial via telephone
follow-up within 1 week of the workshop.
Across all sites, a subsample of participants will be recruited for an
ethnographic study that aims to explore continence stigma, aging, and
participant perspectives of the intervention and control workshops. Data
from the qualitative interviews will help the team understand the
mechanisms and outcomes of the intervention on self-stigma related to
incontinence. Approximately 20 participants will be interviewed within
2 weeks of the workshop to explore participant perspectives of the
intervention and control workshops, and related feelings associated with
continence and age-related stigma. A second group of 20 participants will
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be interviewed 1 year after the intervention workshop. Five participants
from each trial site will be purposively selected from those who have
shown significant benefit from the continence promotion intervention, to
investigate the impact on stigma and to understand the mechanisms behind
the perceived benefits of the workshop.
Randomization
Randomization/Concealment of allocation
Randomization will occur prior to delivery of the intervention. The unit of
randomization will be the community organization. Using block
randomization with an alternating block size of 2 or 4, we will randomly
allocate clusters (via a 1:1 ratio and stratified by site) to the intervention or
control group via a computer-generated random digit performed by an
independent statistician (Fig. 2 ). Stratification by site will aim to account
for any variation resulting from site characteristics and participants from
individual community organizations. The trial is, nonetheless, considered
open-label because both the research assistant who delivers the
interventions and the study participants who will have received the
interventions will be aware of group allocation at the time of
implementation.
Blinding
The trial is blinded at the level of cluster randomization: community
organizations are aware that their participants will receive one of the two
interventions, but they will be blinded to group allocation. Participants will
be aware of which intervention they receive as the intervention is
open-label. A research assistant, who will be blinded to group allocation,
will inform, deliver and complete the questionnaires after each telephone
follow-up. A statistician blinded to the allocation will conduct the analysis
and reporting of the co-primary outcome measures.
Intervention
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The continence promotion intervention is a single 45-minute interactive
group continence promotion program delivered by a trained research
assistant/workshop facilitator. The continence intervention incorporates
constructivist learning and discusses the risk factors, causes and treatments
for incontinence and challenges the misconception that incontinence is a
normal part of aging. It aims to motivate community-dwelling women to
initiate evidence-based self-management and/or to consult for treatment
[ 26 – 30 ]. The intervention workshop is introduced as an educational
workshop addressing “taboo” topics related to aging (memory problems
and incontinence). Risk factors and different etiologies for incontinence
are reviewed, physiology and pathology explained in lay terms and
modifiable strategies for risk reduction are recommended. A paper-based
self-management tool is provided at the end of the workshop to help
participants monitor their symptoms before and after attempting
evidence-based self-management strategies. This paper-based tool asks
women to identify one of the risk factors they may have for urine leakage
and to implement a strategy for risk reduction. This is the same
intervention that was tested in the pilot trial [ 26 ].
The sham control intervention (the comparator) for this study is a single
45-minute interactive group workshop on other health topics of importance
to older women. The topics discussed are memory problems, medication
interactions, sleep problems, and hearing loss. Incontinence is mentioned
briefly during the sham control intervention in order to integrate it with the
questionnaire that revolves around bladder problems.
A fidelity protocol and checklist for delivery of the intervention will be
applied every 6 months to each study site, in order to ensure standardized
implementation of the intervention in each country.
Study follow-up
Study follow-up will include five telephone calls. The first within a week
of the workshop then at, 3, 6, 9 and 12 months post workshop. Telephone
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interviews normally last from 5 to 40 minutes.
Outcomes
Improvement in urinary incontinence at 12 months
The co-primary outcome will be the participant’s global impression of
improvement in incontinence symptoms, measured at 1-year post
intervention by telephone interview using the Patient’s Global Impression
of Improvement (PGI-I) questionnaire. The PGI-I is a validated,
single-item global rating of change scale that asks the patient to describe
how their incontinence condition is now compared to how it was prior to
the intervention (very much better, much better, a little better, no change, a
little bit better, much worse and very much worse) [ 31 ]. Significant
improvement will be defined as participants rating their incontinence
symptoms as much better or very much better. This measure showed
excellent acceptability, known-group validity, reliability and
responsiveness during the pilot study [26 ]. The PGI-I questionnaire will
be administered at 3 months, 6 months and 1 year post intervention to all
participants in all countries by the research assistant at each site (Table 1 ).
Table 1
Timeline of study assessment and data collection
Questionnaires
Baseline 1 week 3 months 6 months 9 months
T0 T1 T2 T3 T4
Pre-workshop
Telephone
follow-up
and
enrollment
confirmation
Telephone
follow-up
Telephone
follow-up
Telephone
follow-up
PGI-I  ✓ ✓ ✓  
ICIQ-FLUTS International Consultation on Incontinence-Female Lower Urinary Tract Symptoms,
I-QOL Incontinence Quality of Life, PGI-I Patient’s Global Impression of Improvement, 
12-item Short Form Survey
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Questionnaires
Baseline 1 week 3 months 6 months 9 months
T0 T1 T2 T3
Pre-workshop
Telephone
follow-up
and
enrollment
confirmation
Telephone
follow-up
Telephone
follow-up
Telephone
follow-up
ICIQ-FLUTS International Consultation on Incontinence-Female Lower Urinary Tract Symptoms,
I-QOL Incontinence Quality of Life, PGI-I Patient’s Global Impression of Improvement, 
12-item Short Form Survey
ICIQ-FLUTS ✓   ✓  
I-QOL ✓   ✓  
Falls Diary  ✓ ✓ ✓ ✓
SF-12 ✓   ✓  
Cost
questionnaire   ✓ ✓ ✓
Secondary outcomes such as self-reported rates of self-management for
treating urinary symptoms and/or seeking professional help will be
collected using identical methods from our pilot study [ 26 ]. Further, to
help determine the process by which the intervention leads to significant
improvement in incontinence, the International Consultation on
Incontinence-Female Lower Urinary Tract Symptoms (ICIQ-FLUTS)
questionnaire will measure the frequency, severity and bother from
incontinence [ 32 ]. The ICIQ-FLUTS will be administered at baseline to
screen participants for inclusion to the trial, and repeated at 6 months and
12 months post intervention (Table 1 ). The ICIQ-FLUTS diagnostic item
will be used by participants to describe the type of incontinence at
baseline.
Stigma and quality of life
The second co-primary outcome will be the difference in quality of life and
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stigmatization between the intervention and control groups. The 22-item
Incontinence Quality of Life questionnaire (I-QOL) is a validated quality
of life instrument for urinary incontinence that includes content relevant to
stigma, such as “I worry about others smelling urine on me” and “I worry
about being embarrassed or humiliated because of my incontinence” [ 33 ].
Exploration of stigma perceptions will be supplemented by the data
collected in the qualitative interviews among a sub-group of participants
immediately after, and at 1 year post intervention. Data will be collected
using semi-structured one-to-one interviews. The qualitative investigation
will also be used in the development of the Continence Psychosocial
Impact of Assistive Devices Scale (C-PIADS), which is being developed
from the original validated Psychosocial Impact of Assistive Devices Scale
(PIADS). PIADS is a 26-item self-report questionnaire that includes 3
domains: competence (reflecting perceived functional capability,
independence and performance); adaptability (reflecting inclination or
motivation to participate socially and take risks); and self-esteem
(reflecting self-confidence, self-esteem, and emotional well-being). This
team is developing a modified version of this measure, C-PIADS that will
evaluate the impacts of continence care product use on psychosocial
constructs including perceived stigma [ 34 , 35 ]. In addition to the original
26 items, the present version of the C-PIADS includes an additional 7
items, including self-consciousness, fear of being “outed,”’ social
acceptance, secrecy, isolation, revealing to others, social participation and
intimate relations. The C-PIADS will be administered on two occasions,
after completion of the ethnographic interview, and on the telephone
1 week after the ethnographic interview.
Falls
The third co-primary outcome measure will be falls experienced by women
exposed to the continence intervention compared to women exposed to the
sham treatment 1 year postintervention. Falls will be measured as the
group rate of falls at 12 months; the proportion of women who had a fall;
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and the proportion of injurious falls. Falls will be defined as an unexpected
event in which the person comes to rest on the ground, floor or lower level
[ 36 ]. Data for falls will be obtained from a falls diary with telephone
reminders [ 37 ]. Previous work has shown that falls diaries pose significant
advantage over other methods of capturing falls among older-aged people
[ 37 ].
Incremental cost-effectiveness ratio and quality-adjusted life years
We will conduct both cost-effectiveness and cost-utility analysis (CEA and
CUA) to explore and quantify the cost per health (or utility) gain. The
primary measure of effectiveness for CEA will be presented as the
incremental cost-effectiveness ratio (ICER), defined as the additional cost
per participant achieving an improvement in urinary incontinence over a
1-year period. The SF-6D measure of health-related quality of life will be
used to calculate utility scores for the estimation of quality-adjusted life
years (QALYs) for the CUA. Derivation of the SF-6D is from item
responses on the SF-12 questionnaire, a generic health- related quality of
life measure, across 6 dimensions: physical functioning, role limitations
due to physical health, bodily pain, vitality, social functioning, role
limitations due to emotional problems, and mental health [ 38 ]. The QALY
is a measure of a participant’s life expectancy, weighted by their health-
related quality of life, valued on a self-reported utility score, where a score
of 1 reflects perfect health and 0 is equivalent to dead [ 38 ]. The
incremental cost per QALY gained will be estimated at 1 year post
intervention and will be depicted in a cost-effectiveness analysis decision
tree. The SF-12 questionnaire will be administered at baseline and at
6-months and 12-months post intervention, while the cost questionnaires
will be administered at 3-month, 6-month, 9-month and 1-year follow-up
to the study participants (Table 1 ).
Sample size
The sample size calculations were not equivalent for all the co-primary
outcomes of the study and, therefore, differ based on the various outcomes.
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We hypothesize that the sample size required to demonstrate the
effectiveness of the continence promotion intervention will be sufficient as
it is powered to detect a minimally clinical important difference of 20 % in
the proportion of participants globally rating their improvement in urinary
symptoms as “much better” or “very much better,” with an expected
change in the control group of 6 % [ 39 ]. As the design is a cluster
randomized trial, we need to adjust for both the clustering and the effect of
unequal cluster sizes [ 40 ]. Based on the results from the pilot study [26 ],
an estimated average cluster size of 4 participants and an intra-class
correlation coefficient (ICC) of 0.02, we would require a minimum of 14
community organizations per arm (a minimum of 56 participants per arm)
to be able to detect a difference of 20 %, with 80 % power and alpha 0.05.
To account for attrition, which we estimate to be around 15 %, we decided
to set the recruitment target to at least 100 participants per arm.
The sample size needed for the falls outcome anticipates an average
baseline fall rate per group of 30 % [ 26 ], and hypothesizes that the
intervention will have an effect on the incidence rate of falls of 0.21 (30 %
relative reduction). A minimum sample size of 388 per group (at least 97
community organizations per group) is needed to detect this minimally
important difference with 80 % power, 5 % level of significance, an ICC of
0.02 and an average cluster size of 4.
Sample size for the economic analysis was calculated using a mapping
exercise to convert a minimally important difference on the I-QOL to the
SF-12 to account for the possibility that the SF-12, a generic quality of life
measure, may be insufficiently sensitive to reflect important differences in
incontinence-related quality of life [ 39 ]. An improvement of 6.65 points
on the I-QOL scale best matched an improvement (as much better or very
much better) on the PGI-I, which we defined as a minimally important
difference. Then, using a Monte Carlo simulation, we calculated that using
this change cut-off, a detectable difference of 4.74 on the I-QOL between
the intervention and control groups, would be statistically significant (at
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0.05 alpha level) in at least 80 % of simulations when each group
comprises at least 500 participants, representing a gain of 0.0126 in SF-6D
utility scores.
Taking into account the sample size calculation for all co-primary outcome
measures, we therefore aim to recruit the participants according to the
largest sample size that will be sufficient for sub-group analyses (n  =  500
participants per group) – a total of 1000 participants.
Data analysis
Co-primary outcomes
Differences in baseline characteristics between the groups will be
determined using descriptive statistics (means, proportions), to assess any
imbalance in potential confounders. All analyses will be done on an
intention-to-treat basis. To assess improvements in incontinence, we will
estimate the unadjusted risk difference (prevalence of the outcome) and 95
% confidence interval (CI) via generalized estimating equations (GEEs)
with an identity link and an exchangeable correlation structure to account
for possible correlation between women in the same organization [41 ].
The effects of various potential confounders in the groups at baseline will
be explored because of the possibility for selection bias in an open trial. To
adjust for imbalance in potential confounders, additional analyses will be
conducted using multivariate logistic regression estimated via GEE with an
exchangeable correlation structure. As a sensitivity analysis, we will repeat
the analysis on a per protocol basis that will include participants who
adhered to the protocol and follow-ups.
Incontinence-specific quality of life will be assessed using the
Incontinence Quality of Life Instrument (I-QOL). The 22 items in the
I-QOL will be summed and then transformed to a 0 to 100 scale for greater
interpretability, with the higher scores representing greater quality of life.
The I-QOL subscales (avoidance or limiting behaviors, psychological
impacts, social life impact, and social embarrassment) will be scored in an
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identical manner. In an ad hoc analysis, crude effect sizes, examining
change in scale scores at each assessment within participant group
(intervention and control), will be calculated and evaluated using Cohen’s
d criteria (i.e., 0.2–0.49 is small, 0.5–0.79 is moderate, and 0.8 and above
is large). Multivariate linear models will be used to compare each I-QOL
subscales score reported by the intervention group to the control group,
with the control group as the referent and participants clustered by
organization. Age at baseline and other potential confounders will be
included as covariates in all adjusted models.
Fall rates in the intervention and the control groups will be analyzed as
follow: (1) the incidence rate of falls, using Poisson regression to allow for
clustering of falls by the same participant, (2) the proportion of patients
who had one or more falls versus no falls, using logistic regression
analyses, and (3) the proportion of injurious falls, using logistic regression
analyses. Each analysis will use patient-level data that will be clustered by
organization and analyzed via GEE with an exchangeable correlation
structure and a log and a logit link for Poisson and logistic regression
analyses respectively. Negative binomial regression will be used to model
the incidence rate of falls, if there is evidence of over-dispersion of the
data using Poisson regression. Multivariate analyses will adjust for any
confounding variables that may affect the relationship between
incontinence and falls.
Analysis of the qualitative sub-study on stigma
The interview data on stigma will be analyzed using the principles of
content description. The goal of content analysis is to generate a group of
concepts that describes primary research questions. All text that addresses
the fundamental research questions will be coded, whereby relevant text
will be assigned a “heading” in the margin of the transcript. Headings will
be reviewed, and categories of headings created. In the final step of
content analysis, investigators will identify meaningful patterns within and
across interview transcripts, and prepare general descriptors of the data.
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For this step, we will upload the data into ATLAS-ti, a software program
designed to aid in the analysis of large bodies of text.
AQ3
Economic analysis
In this analysis we will assess the cost of the continence promotion
program for senior women with incontinence compared to the sham control
group. The study will involve constructing a decision analytic model
through which we will estimate the cost-effectiveness and cost-utility of
the intervention. This will take the form of a decision tree and will be
based directly on the prevalence for the global rating of improvement (as
“much better” or “very much better”) in urinary incontinence as the
outcome (Fig. 3 ). Each of the branches in the decision tree represents a set
of actions or strategies under assessment and will be populated with data
on probability, costs and utilities obtained from data collection in the
study. The decision tree remains identical for every option in the model,
although probabilities change.
Fig. 3
Decision  tree  model  for  the  cost-effectiveness  analysis.  Legend:
decision-tree model for the cost-effectiveness analysis. The square indicates
group randomization; the circles indicate chance nodes; the triangles indicate
terminal nodes
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Data and parameter estimates specific to Canada will be used to calculate
the ICERs, first from a societal perspective and then from a healthcare
system perspective. ICERs for the healthcare system perspective as base
case will be of interest to site-specific health policy makers for resource
allocation decisions, should the continence promotion intervention be
found effective. Critically, the ICER from a societal perspective will
facilitate discourse on the full opportunity cost of individual pad use in the
context of the selected site. The results of the CEA will be expressed as
cost per percentage improvement in the prevalence of urinary incontinence
as measured by PGI-I and the results of the CUA will be expressed as cost
per QALY gained. The ICER from the CEA will be comparable with other
continence intervention programs using the same outcome measure
(improvement in urinary incontinence), while QALYs from the CUA is a
more standardized measure (not specific to the outcome measure) and will
be comparable more broadly.
A probabilistic sensitivity analysis will be undertaken using the
uncertainty estimates, in which the key model’s parameters will be
replaced with plausible values drawn from specified probability
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distribution assigned to those parameters. Uncertainty surrounding the
cost-effectiveness and cost-utility results will be provided by plotting
replications on the cost-effectiveness and cost-utility plane and reviewed in
cost-effectiveness and cost-utility acceptability curves.
Discussion
This study aims to evaluate the impact of a continence promotion
intervention on community-dwelling older women with untreated
incontinence. Previous research suggests that an intervention combining
constructivist learning and an evidence-based self-management tool is
effective in reducing urinary symptoms. [ 26 ] The current study will
investigate whether the benefits of this continence promotion intervention
extend to a reduction in falls and stigma, improvements in quality of life
and social participation, and gains in healthy active life expectancy.
Generalizability to different cultural settings will be achieved by testing
the intervention across three countries in both English and French to
determine its effect on multiple co-primary outcomes.
Strengths
The strengths of this study include the robust randomized controlled trial
design with baseline and long-term follow-up, the quantitative and
qualitative mixed analysis and the use of multiple measures as primary
outcomes. Additionally, the international platform for this study will
facilitate rapid accrual of sample size and external validity at minimum
cost, while meeting the needs of regulatory agencies in different
jurisdictions. The synergies enabled by the intervention have the potential
to produce a paradigm shift in attitudes toward incontinence in older
women, and among health professionals empowered to address
multimorbidity in an aging population. Although incontinence has been
associated with falls, to date no trial exists that causally links reductions in
falls to exposure to a continence promotion intervention that improves
urinary symptoms. Furthermore, this is the first trial to assess the impact of
incontinence symptom improvement, fall reduction and quality of life on
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QALYs and healthy active life expectancy in older women.
Limitations
There are a few limitations to our study. Many of our outcome measures
are by self-report, though supplemented with objectively measured data
whenever possible. We attempted to use a bladder diary to measure
improvements in incontinence during our pilot study [ 26 ] in the UK,
however, a large proportion of unreliable or missing data was collected.
Further, for incontinence severity of less than once every 2 days, the
responsiveness of this measure is poor [ 42 ]. We acknowledge the
possibility of recall bias for the baseline measures and importantly, the
diary falls entry. However, we tried to limit this bias by implementing
telephone follow-up reminders.
Post-randomization recruitment bias is also a possibility for participants
who have not been screened for incontinence prior to randomization of the
clusters [ 27 ].
Knowledge translation
Knowledge translation is assured as our recruitment strategies reach out
directly to community organizations and their constituents. The results of
this study will be communicated to community stakeholders and the
general public as an incontinence awareness initiative. Our ultimate goal
will be to contribute to discussions around public health social policy
change to support a more proactive society-wide management of
incontinence. The progress of the study, interim and final results will be
presented at relevant national or international conferences. Manuscripts
will be submitted for publication in peer-reviewed journals. The aim is to
make the intervention accessible in a train-the-trainers format to
community organizations and primary care institutions after completion of
the study.
Potential impact
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Incontinence increases with age and is strongly associated with reduced
self-esteem, social isolation, depression, and a higher likelihood of
dependency and institutionalization. The current lack of social policies and
public health initiatives surrounding community-based continence
promotion strategies offers a fertile ground on which to build this study
and a stepping stone for developing continence expertise in other related
settings such as hospitals and long-term care. Despite the high prevalence
of incontinence in seniors, there is a surprising lack of evidence-based
public health campaigns to improve continence among older women and to
reduce the stigma, negative beliefs and loss of functional independence
associated with incontinence.
This study will use a novel constructivist group intervention combined
with innovative evidence-based self-management tools for older
community-dwelling women with incontinence, with the aim of increasing
disability-free lifespan and quality of life. The economic analysis will
determine the costs incurred by the continence promotion intervention and
facilitate a realistic budget impact assessment that can be used to
supplement sustainable interventions for healthy aging.
Evidence linking continence promotion to fall reduction and improvements
in healthy active life expectancy will inform future public policy and fall
prevention programs.
Trial status
The trial is currently recruiting participants and is approximately 60 %
complete at the time of submission.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
CT, EH, XF, KS, JJ and AW conceived the study, participated in its
e.Proofing http://eproofing.springer.com/journals/printpage.php?token=l39...
26 of 32 2015-12-08, 9:05 AM
design/coordination and helped to revise the manuscript. CT, SR, and AW
were involved in drafting the manuscript. All authors read and approved
the final manuscript.
Acknowledgments
The study is funded by the European Research Area on Ageing2
(ERA-AGE2) program, with joint contributions from the Canadian
Institutes of Health Research, the Fonds de la Recherche en Santé du
Québec, the Economic and Social Research Council of the UK, the Institut
National de Prévention et Éducation pour la Santé de la France, and the
Agence Regional de Santé Publique de Poitou-Charentes.
References
1.  Herschorn S, Gajewski J, Schulz J, et al. A population-based study
of urinary symptoms and incontinence: the Canadian Urinary Bladder
Survey. BJU Int. 2008;101(1):52–8.
doi:10.1111/j.1464-410X.2007.07198.x.
AQ4
2.  Tannenbaum C, Corcos J, Assalian P. The relationship between
sexual activity and urinary incontinence in older women. J Am Geriatr
Soc. 2006;54(8):1220–4. doi:10.1111/j.1532-5415.2006.00827.x.
3.  Buckley BS, Lapitan MCM. Prevalence of urinary and faecal
incontinence and nocturnal enuresis and attitudes to treatment and
help-seeking amongst a community-based representative sample of
adults in the United Kingdom. Int J Clin Pract. 2009;63(4):568–73.
doi:10.1111/j.1742-1241.2008.01974.x.
4.  Fritel X, Panjo H, Varnoux N, et al. The individual determinants of
care-seeking among middle-aged women reporting urinary
incontinence: analysis of a 2273-woman cohort. Neurourol Urodyn.
2014;33(7):1116–22. doi:10.1002/nau.22461.
e.Proofing http://eproofing.springer.com/journals/printpage.php?token=l39...
27 of 32 2015-12-08, 9:05 AM
5.  Mitteness LS, Barker JC. Stigmatizing a “normal” condition: urinary
incontinence in late life. Med Anthropol Q. 1995;9(2):188–210.
doi:10.1525/maq.1995.9.2.02a00050.
6.  Farage M, Miller K, Berardesca E, et al. Psychosocial and societal
burden of incontinence in the aged population: a review. Arch Gynecol
Obstet. 2008;277(4):285–90. doi:10.1007/s00404-007-0505-3.
7.  Johnson TM, Kincade JE, Bernard SL, et al. The association of
urinary incontinence with poor self-rated health. J Am Geriatr Soc.
1998;46(6):693–9. doi:10.1111/j.1532-5415.1998.tb03802.x.
8.  Dugan E, Cohen SJ, Bland DR, et al. The association of depressive
symptoms and urinary incontinence among older adults. J Am Geriatr
Soc. 2000;48(4):413–6. doi:10.1111/j.1532-5415.2000.tb04699.x.
9.  Chiarelli PE, Mackenzie LA, Osmotherly PG. Urinary incontinence
is associated with an increase in falls: a systematic review. Aust J
Physiother. 2009;55(2):89–95. http://dx.doi.org/10.1016
/S0004-9514(09)70038-8.
10.  Tannenbaum C, Gray M, Hoffstetter S, Cardozo L. Comorbidities
associated with bladder dysfunction. Int J Clin Pract.
2013;67:105–1013. doi:10.1111/ijcp.12085.
11.  Godmaire GC, Grenier S, Tannenbaum C. An independent
association between urinary incontinence and falls in chronic
benzodiazepine users. J Am Geriatr Soc. 2015;63(5):1035–7.
doi:10.1111/jgs.13424.
12.  Fritel X, Lachal L, Cassou B, Fauconnier A, Dargent-Molina P.
Mobility impairment is associated with urge but not stress urinary
incontinence in community-dwelling older women: results from the
Ossebo study. BJOG. 2013. doi:10.1111/1471-0528.12316.
e.Proofing http://eproofing.springer.com/journals/printpage.php?token=l39...
28 of 32 2015-12-08, 9:05 AM
13.  Foley AL, Loharuka S, Barrett JA, et al. Association between the
geriatric giants of urinary incontinence and falls in older people: data
from the Leicestershire MRC Incontinence Study. Age Ageing.
2012;41:35–40. doi:10.1093/ageing/afr125.
14.  Takazawa K, Arisawa K. Relationship between the type of urinary
incontinence and falls among frail elderly women in Japan. J Med
Invest. 2005;52:165–71.
15.  Beauchet O, Annweiler C, Allali G, Berrut G, Herrmann FR,
Dubost V. Recurrent falls and dual task-related decrease in walking
speed: is there a relationship? J Am Geriatr Soc. 2008;56(7):1265–9.
doi:10.1111/j.1532-5415.2008.01766.x. PubMed.
16.  Gibson W, Wagg A. New horizons: urinary incontinence in older
people. Age Ageing. 2014;43(2):157–63. doi:10.1093/ageing/aft214.
PubMed.
17.  Kuo H-K, Lipsitz LA. Cerebral white matter changes and geriatric
syndromes: is there a link? J Gerontol A Biol Sci Med Sci.
2004;59(8):M818–26.
18.  Holroyd-Leduc JM, Mehta KM, Covinsky KE. Urinary
incontinence and its association with death, nursing home admission,
and functional decline. J Am Geriatr Soc. 2004;52(5):712–8.
doi:10.1111/j.1532-5415.2004.52207.x.
19.  Wilson L, Brown JS, Shin GP, et al. Annual direct cost of urinary
incontinence. Obstet Gynecol. 2001;98(3):398–406.
20.  Tannenbaum C, Bachand G, Dubeau CE, et al. Experience of an
incontinence clinic for older women: no apparent age limit for potential
physical and psychological benefits. J Womens Health Gend Based
Med. 2001;10(8):751–6. doi:10.1089/15246090152636505.
e.Proofing http://eproofing.springer.com/journals/printpage.php?token=l39...
29 of 32 2015-12-08, 9:05 AM
21.  Min LC, Reuben DB, Adams J, et al. Does better quality of care for
falls and urinary incontinence result in better participant-reported
outcomes? J Am Geriatr Soc. 2011;59(8):1435–43.
doi:10.1111/j.1532-5415.2011.03517.x.
22.  Roberts RO, Jacobsen SJ, Rhodes T, et al. Urinary incontinence in
a community-based cohort: prevalence and healthcare-seeking. J Am
Geriatr Soc. 1998;46(4):467–72.
23.  Stoddart H, Donovan J, Whitley E, et al. Urinary incontinence in
older people in the community: a neglected problem? Br J Gen Pract.
2001;51(468):548–52.
24.  Dugan E, Roberts CP, Cohen SJ, et al. Why older community-
dwelling adults do not discuss urinary incontinence with their primary
care physicians. J Am Geriatr Soc. 2001;49(4):462–5.
doi:10.1046/j.1532-5415.2001.49094.x.
25.  Locher JL, Burgio KL, Goode PS, et al. Effects of age and causal
attribution to aging on health-related behaviors associated with urinary
incontinence in older women. Gerontologist. 2002;42(4):515–21.
26.  Tannenbaum C, Agnew R, Benedetti A, et al. Effectiveness of
continence promotion for older women via community organisations: a
cluster randomised trial. BMJ Open. 2013;3(12):e004135.
doi:10.1136/bmjopen-2013-004135.
27.  Agnew R, van den Heuvel E, Tannenbaum C. Efficiency of using
community organisations as catalysts for recruitment to continence
promotion trials. Clin Trials. 2013;10(1):151–9.
28.  Tannenbaum C, Drali R, Holroyd-Leduc J, Richard L. Lessons
learned: impact of a continence promotion activity for older community
dwelling women. Neurourol Urodyn. 2010;29:540–4.
e.Proofing http://eproofing.springer.com/journals/printpage.php?token=l39...
30 of 32 2015-12-08, 9:05 AM
29.  Holroyd-Leduc J, Strauss S, Thorpe K, Davis D, Schmaltz H,
Tannenbaum C. Translation of evidence into a self-management tool for
use by women with urinary incontinence. Age Ageing. 2011;40:227–33.
30.  Wilde MH, Bliss DZ, Booth J, Cheater F, Tannenbaum C.
Self-management of urinary and fecal incontinence. Am J Nurs.
2014;114(1):38–45.
31.  Yalcin I, Bump RC. Validation of two global impression
questionnaires for incontinence. Am J Obstet Gynecol.
2003;189(1):98–101. http://dx.doi.org/10.1067/mob.2003.379.
32.  International Consultation on Incontinence Modular Questionnaire
(ICIQ). ICIQ- FLUTS Module. Available at http://www.iciq.net
/ICIQ.FLUTS.html
AQ5
. Accessed February 2013.
33.  Wagner TH, Patrick DL, Bavendam TG, et al. Quality of life of
persons with urinary incontinence: development of a new measure.
Urology. 1996;47(1):67–71. http://dx.doi.org/10.1016
/S0090-4295(99)80384-7.
34.  Day H, Jutai J, Campbell KA. Development of a scale to measure
the psychosocial impact of assistive devices: lessons learned and the
road ahead. Disabil Rehabil. 2002;24(1–3):31–7.
doi:10.1080/09638280110066343.
35.  Jutai J, Southall K, van den Heuvel E. Measuring the psychosocial
impact of continence management technologies. Generations Rev - Br J
Gerontol; 2011(April:1–3).
36.  WHO. Violence-injury prevention. Available at:
http://www.who.int/violence_injury_prevention/other_injury/falls/en/
e.Proofing http://eproofing.springer.com/journals/printpage.php?token=l39...
31 of 32 2015-12-08, 9:05 AM
AQ6
. Accessed 14 July 2015.
37.  Perry L, Kendrick D, Morris R, et al. Completion and return of fall
diaries varies with participants’ level of education, first language, and
baseline fall risk. J Gerontol A Biol Sci Med Sci. 2012;67A(2):210–4.
doi:10.1093/gerona/glr175.
38.  Brazier JE, Roberts J. The estimation of a preference-based
measure of health from the SF-12. Med Care. 2004;42(9):851–9.
doi:10.2307/4640827.
39.  Halme AS, Fritel X, Benedetti A, et al. Implications of the Minimal
Clinically Important Difference for Health-Related Quality-of-Life
Outcomes: a comparison of sample size requirements for an
incontinence treatment trial. Value Health. 2015;18(2):292–8.
http://dx.doi.org/10.1016/j.jval.2014.11.004.
40.  Eldridge SM, Ashby D, Kerry S. Sample size for cluster
randomized trials: effect of coefficient of variation of cluster size and
analysis method. Int J Epidemiol. 2006;35(5):1292–300. doi:10.1093/ije
/dyl129.
41.  Ukoumunne OC, Forbes AB, Carlin JB, et al. Comparison of the
risk difference, risk ratio and odds ratio scales for quantifying the
unadjusted intervention effect in cluster randomized trials. Stat Med.
2008;27(25):5143–55. doi:10.1002/sim.3359.
42.  Homma Y, Ando T, Yoshida M, et al. Voiding and incontinence
frequencies: variability of diary data and required diary length.
Neurourol Urodyn. 2002;21(3):204–9. doi:10.1002/nau.10016.
e.Proofing http://eproofing.springer.com/journals/printpage.php?token=l39...
32 of 32 2015-12-08, 9:05 AM
